SharesGrow.com Intrinsic Value of S&P & Nasdaq Contact Us

हिन्दी

← Back to all stocks

Denali Therapeutics Inc. DNLI NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score

SharesGrow Intrinsic Value

Negative cash flow

Analyst Price Target

Denali Therapeutics Inc. (DNLI) has 12 identified peers for comparison in the Healthcare sector. Peers include AKRO, APLS, ASND, BCEL, BDTX, BGNE and others.

DNLI has a market capitalization of $3.2B, compared to an average peer market cap of $5.46B.

Peers & Similar Companies — DNLI

Akero Therapeutics, Inc.

$54.65 0.00% $4.5B

Apellis Pharmaceuticals, Inc.

$40.85 +0.02% $5.22B

Ascendis Pharma A/S

$249.84 +0.52% $15.34B

$0.09 -1.32% $3.57M

Black Diamond Therapeutics, Inc.

$2.66 -2.21% $152.39M

$184.71 +0.49% $20.21B

Blueprint Medicines Corporation

$129.46 +0.14% $8.36B

Cerevel Therapeutics Holdings, Inc.

$44.96 +0.74% $8.19B

Day One Biopharmaceuticals, Inc.

$21.46 -0.14% $2.22B

Design Therapeutics, Inc.

$12.64 +2.35% $779.54M

4D Molecular Therapeutics, Inc.

$9.66 -3.78% $493.16M

Homology Medicines, Inc.

$0.93 +0.77% $3.02M

People Also View

Revolution Medicines, Inc.

Ascendis Pharma A/S

Blueprint Medicines Corporation

Cerevel Therapeutics Holdings, Inc.

Apellis Pharmaceuticals, Inc.

Akero Therapeutics, Inc.

Contact Us

🎓

SharesGrow Academy

Learn how to calculate Intrinsic Value and find undervalued stocks.

Weekly live sessions

📧 [email protected]

📞 +65 8912 8000

Send us a message